IntegraGen SA (ALINT):医療機器:M&Aディール及び事業提携情報

【英語タイトル】IntegraGen SA (ALINT) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C7283)・商品コード:DATA904C7283
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:35
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics, and genomics news, genomic research tools and solutions to microbiologic researchers. It also offers DNA extraction, management samples, study design, strategy, selection markers, tagging, biostatistics analysis and bioinformatics analysis of sequence data services, among others. IntegraGen develops miR-31-3p, a microRNA biomarker for metastatic colorectal and lung cancer. The company offers services in the fields of pharmacogenetics, cytogenetics, epigenetics and agriculture. It caters to patients, clinicians and researchers. The company has operations in France and the US. IntegraGen is headquartered in Paris, France.

IntegraGen SA (ALINT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IntegraGen SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IntegraGen SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
IntegraGen SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IntegraGen SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
IntegraGen SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
IntegraGen SA, Medical Equipment, Deal Details 10
Partnerships 10
GoPath Labs Enters into Licensing Agreement with IntegraGen 10
Laboratoire CERBA Enters into Licensing Agreement with IntegraGen 11
IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 12
IntegraGen Enters into Distribution Agreement with Twist Bioscience 14
Lab21 Enters Into Agreement With IntegraGen To Develop Cancer Diagnostic 15
Equity Offering 16
IntegraGen Raises USD4 Million in Private Placement of Shares 16
IntegraGen Completes Private Placement Of Shares For US$2.5 Million 17
IntegraGen SA – Key Competitors 18
IntegraGen SA – Key Employees 19
IntegraGen SA – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Sep 20, 2018: Integragen announces 17% increase in sales revenue and a 57% increase in operating profit for the first half of 2018 21
Apr 13, 2018: IntegraGen Reports 2017 Annual Results 23
Jan 09, 2018: IntegraGen Reports 2017 revenue and cash position 25
Sep 29, 2017: IntegraGen Reports Financial Results for 1st Half of 2017 26
Jul 11, 2017: Integragen Reports Continued Growth During 1st Half Of 2017 28
Apr 21, 2017: IntegraGen Announces 2016 Annual Results: Increase in operating revenues and significant improvement in operating income (+22%) 29
Jan 09, 2017: IntegraGen Reports Sharp Increase in Sales During 2016 32
Legal and Regulatory 33
Apr 23, 2018: IntegraGen Achieves ISO 13485:2016 Certification for the Design, Manufacturing and Distribution of In Vitro Diagnostic Kits 33
Other Significant Developments 34
Jan 18, 2018: IntegraGen Launches SIRIUS and MERCURY – Big Data Tools Which Enable Ultra-Efficient Exploration of Large-Scale Genomic Data 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
IntegraGen SA, Medical Equipment, Key Facts, 2017 2
IntegraGen SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
IntegraGen SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IntegraGen SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
IntegraGen SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IntegraGen SA, Deals By Market, 2012 to YTD 2018 8
IntegraGen SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GoPath Labs Enters into Licensing Agreement with IntegraGen 10
Laboratoire CERBA Enters into Licensing Agreement with IntegraGen 11
IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 12
IntegraGen Enters into Distribution Agreement with Twist Bioscience 14
Lab21 Enters Into Agreement With IntegraGen To Develop Cancer Diagnostic 15
IntegraGen Raises USD4 Million in Private Placement of Shares 16
IntegraGen Completes Private Placement Of Shares For US$2.5 Million 17
IntegraGen SA, Key Competitors 18
IntegraGen SA, Key Employees 19
IntegraGen SA, Subsidiaries 20

List of Figures
IntegraGen SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
IntegraGen SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
IntegraGen SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
IntegraGen SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
IntegraGen SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IntegraGen SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
IntegraGen SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IntegraGen SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★調査レポート[IntegraGen SA (ALINT):医療機器:M&Aディール及び事業提携情報] (コード:DATA904C7283)販売に関する免責事項を必ずご確認ください。
★調査レポート[IntegraGen SA (ALINT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆